PACT’s experience with such companies as SmithKline Beecham, Johnson and Johnson, Novartis, Sanofi Aventis, Pfizer, Wyeth among other pharmaceutical companys has been rewarding in acquiring the necessary know-how. Treatment processes used cover biological, chemical and membrane separation. Biological processes implemented by PACT cover both aerobic and anaerobic. Aerobic processes were enhanced by utilizing SBR and MSABP versions for higher efficiency and low sludge generation. Membrane separation are utilized successfully for treatment of wastes that are not tolerated by biological processes (toxic content) and those wastes that are oil-based.

PACT's Patial Reference of Water & Wastewater Treatment in Pharmacy Industry




Success Sharing-Novartis AG

Novartis AG's core business covers patent and nonpatent medicines, eyescare, healthcare and animal care. Headquatered in Basel, Swiss, Novartis AG's business spreads in more than 140 countries with 82,000 staff . PACT provides an EPC solution of wastewater treatment for Norvartis AG Changshu Plant in China. 

Novartis AG(Changshu)Wastewater Characteristics And The Treatment Solution

The wastewater to be treated in the wastewater treatment plant includes following streams:

-Storm water and fire water
-Sanitary sewage from toilets and showers
-Process wastewater
-Bunded sewer
The wastewater treatment plant is designed to handle up to 1,000 m3/day wastewater with a concentration of 5,000 mg/L Chemical Oxygen Demand (COD). Effluent meet discharging standard after chemical and biological combined treament provided by us. 
Effluent Discharging Standard Of Novartis AG (Changshu) WWTP


Discharging Standard
6 – 9
Suspended Solids
< 150 mg/L
Total BOD5
< 120 mg/L
Total CODcr
< 350 mg/L
< 0.5 mg/L
< 0.1 mg/L